Ginkgo Bioworks Holdings, Inc. (DNA)
After hours:
| Previous close | 0.3366 |
| Open | 0.3343 |
| Bid | 0.3520 x 900 |
| Ask | 0.3650 x 2900 |
| Day's range | 0.3319 - 0.3789 |
| 52-week range | 0.2640 - 2.5200 |
| Volume | |
| Avg. volume | 59,974,774 |
| Market cap | 824.954M |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals
Syngenta Crop Protection, a leader in agricultural innovation, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new collaboration aimed at accelerating the launch of a new biological solution. The two companies have previously collaborated on next-generation seed technology.
- PR Newswire
Ginkgo Bioworks to Participate in Two Conferences in May
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that management will be participating in two investor conferences in May.
- PR Newswire
Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
Sojitz, a large Japanese general trading company with extensive networks within the Japanese bioeconomy, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a binding definitive agreement. Together, Sojitz and Ginkgo aim to build connections with key Japanese businesses and encourage the use of synthetic biology to develop sustainable production processes.
